| |
| |
|
| Insider
Information: |
Doumani Roy |
| Relationship: |
Director |
| City: |
Venice |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kite Pharma, Inc. |
KITE |
Director |
2017-10-03 |
0 |
2017-10-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-10-03 |
4 |
D |
$180.00 |
$4,511,700 |
I/I |
(25,065) |
0 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-10-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,807) |
0 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-10-03 |
4 |
D |
$180.00 |
$27,111,600 |
D/D |
(150,620) |
1,807 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,410 |
152,427 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-06-08 |
4 |
S |
$84.53 |
$422,634 |
D/D |
(5,000) |
150,017 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-06-07 |
4 |
S |
$84.46 |
$844,621 |
D/D |
(10,000) |
155,017 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-03-01 |
4 |
OE |
$1.35 |
$67,500 |
D/D |
50,000 |
75,065 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-03-01 |
4 |
S |
$76.77 |
$214,942 |
I/I |
(2,800) |
25,065 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-03-01 |
4 |
S |
$72.27 |
$1,184,873 |
D/D |
(16,000) |
115,017 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2016-06-06 |
4 |
S |
$58.38 |
$233,516 |
I/I |
(4,000) |
27,865 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2016-06-06 |
4 |
S |
$57.56 |
$579,065 |
D/D |
(10,000) |
131,017 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2016-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,950 |
141,017 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
